| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Domain Investment |
|
Main Subject - Domain Investment
Domain investment, or the buying of domain names for profit, has been an internet marketing "insider secret" for a nu According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product mber of years. When the internet was young, for example, enterprising spirits grabbed the domain names of popular com ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in anies and resold them when those companies came knocking. In fact, stories abound on the net about domain names selli lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. g for thousands - and even millions - of dollars each. In 2006 alone, domain names such as "diamonds.com" and "camera here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe .com" sold for a combined $9 million dollars. There is no question that many people have made a bundle selling domain d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro names, including "Domain King" Rick Schwartz, who has made up to $2,000,000 a year through domain investment. Can yo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc make money selling domain names? Unless you're very lucky or already a proficient internet marketer, your chances ar easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi not great that you will be able to find a profitable domain name which hasn't been taken. Many analysts emphasize th nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t investing in domain names is no longer a "walk in the park" and that real "killings" in domain investment are few a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d far between. There is doubtlessly much competition in the field of ever-dwindling dot.com domain names, and even in ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the less used ones as well, such as .net, .info, .biz, .ws, etc. Nevertheless, creative entrepreneurs have not let t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ose facts slow them down, and certain "domain profiteers" have flaunted conventional wisdom and continued to profit i dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod domain investment. Without detailed instructions from such experts with a proven track record, however, chances of f cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ilure are high enough to discourage the novice without deep pockets. The good news is that those who wish to enter th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen lucrative domain-name business can apply a multipart strategy with the following in mind:
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g domain names for a profit ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust > y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products d the field is still wide open, especially with the release of helpful products such as Shawn Casey's "Domain Profite . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r," which provides step by step instructions on how to make profts with domain names. With tools such as these, you c elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip uld learn to do the same thing as the "domain kings" and "domain barons" who have made a fortune in domain investment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Motivational Humorous Speakers Can Help Motivate Meeting Attendees! How to 'Start' Starting your Own Business
|